The Deal
Commercial Lending Solutions arranged $29 million in construction financing for a 78-unit multifamily development in San Francisco, California. The project received approval under California's SB 423, also known as the Builder's Remedy statute, which allows developers to bypass local zoning restrictions and receive streamlined approval if their projects meet specific affordability requirements.
The development includes 15% of units designated as affordable housing at 80% Area Median Income (AMI), satisfying SB 423's affordability mandate. The construction loan was structured at 60% loan-to-cost with a 30-month initial term and a 6-month extension option. The project represents a significant test case for SB 423's effectiveness in expediting housing development in California's most challenging regulatory environment.
The Challenge
San Francisco presents the most expensive construction market in the United States, with hard costs often exceeding $800 per square foot for multifamily projects. Even with SB 423's streamlined approval process, lenders remained skeptical about San Francisco's ability to deliver predictable timelines and avoid regulatory complications that could derail construction schedules.
The primary challenge was finding a construction lender comfortable with both San Francisco's complex regulatory landscape and the relatively new SB 423 approval pathway. Many national construction lenders avoid San Francisco entirely due to cost overrun risks and permit delays. Local lenders who understood the market were concerned about SB 423's untested nature and potential legal challenges from municipal authorities resistant to state override of local zoning control.
Additionally, the project's 15% affordability requirement created underwriting complexity. Lenders needed to evaluate the income restrictions' impact on stabilized cash flow while assessing the developer's ability to navigate San Francisco's inclusionary housing requirements and potential compliance monitoring.
The Solution
We identified a Bay Area regional bank with established expertise in California's housing legislation landscape and a track record of successful SB 423 project financing. This lender had previously financed multiple Builder's Remedy projects and developed internal underwriting protocols specifically for streamlined approval developments.
The loan structure addressed San Francisco's construction risks through conservative leverage at 60% LTC, providing adequate equity cushion for cost overruns. The 30-month initial term with 6-month extension accommodated San Francisco's construction timeline realities while the extension option provided buffer against weather delays or permit complications that could still arise despite streamlined approval.
The lender's familiarity with AMI compliance requirements streamlined underwriting of the affordable component. Their existing relationships with San Francisco's planning department and understanding of SB 423's legal framework gave them confidence in the approval's durability against potential municipal challenges.
Critical to the placement was the lender's recognition that SB 423 projects, despite initial skepticism from some market participants, represented lower entitlement risk than traditional San Francisco developments due to limited municipal discretion in the approval process.
The Outcome
The construction loan closed successfully, enabling the developer to break ground on schedule. The SB 423 streamlined approval process delivered significant time savings, reducing the entitlement timeline by an estimated 24 months compared to San Francisco's traditional discretionary review process. This timeline compression translated to substantial carrying cost savings and reduced market risk exposure for the developer.
The financing demonstrates growing lender comfort with Builder's Remedy projects as SB 423 proves effective in its intended purpose of accelerating housing production. The regional bank's willingness to provide competitive pricing reflected their assessment that streamlined approval actually reduces certain project risks despite San Francisco's challenging construction environment.
For the broader market, this transaction represents an important precedent for SB 423 financing in California's highest-cost markets. The successful placement shows that construction capital is available for Builder's Remedy projects when developers work with lenders who understand the legislation's mechanics and risk profile.
The project is currently under construction and on schedule, validating both the lender's underwriting approach and SB 423's effectiveness in San Francisco. This success case positions the developer for additional SB 423 projects and demonstrates to other capital sources that streamlined approval developments can achieve traditional construction financing despite initial market uncertainty about the new regulatory framework.